LakeShore Biopharma Co Overview

LakeShore Biopharma Co EBIT

EBIT (Earnings Before Interest and Taxes) analysis for LSB.

Quarterly EBIT

-$3.25M

As of Mar 31, 2024

Annual EBIT (TTM)

-$199.68M

↓ 2021.51% YoY

Trailing 12 months ending Mar 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin